Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020

Date: February 1, 2016
Pages: 167
Price:
US$ 4,650.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: EC412F418BAEN
Leaflet:

Download PDF Leaflet

Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020
The epigenetics market is expected to reach USD 890.0 million by 2020 from USD 469.6 million in 2015, at a CAGR of 13.64% between 2015 and 2020. By product, the market includes enzymes, instruments & consumables, kits and reagents. Enzymes are further subsegmented into DNA-modifying enzymes, protein-modifying enzymes, and RNA-modifying enzymes. Instruments & consumables are further subsegmented into mass spectrometers, next-generation sequencers, qPCRs, sonicators and other epigenetics instruments & consumables. Kits are further subsegmented into bisulfite conversion kits, ChIP-seq kits, RNA sequencing kits, whole genomic sequencing kits, 5-hmc and 5-mc analysis kits and other epigenetics kits. Reagents are further subsegmented into antibodies, buffers, histones, magnetic beads, primers and other epigenetics reagents. The kits segment is expected to grow at the highest rate. Based on research areas, the market is segmented into developmental biology, drug discovery, oncology and other research areas. Other research areas include genome-wide regulatory mechanisms and research related to several metabolic and genetic diseases.

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). North America is further segmented into the U.S. and Canada. North America is expected to account for the largest share in the global epigenetics market in 2015. Asia is expected to register the fastest growth.

Market growth is majorly driven by the high prevalence of cancer, increasing R & D funding and increasing intensity of genomic research activities. Other growth factors include increasing application for non-oncology diseases and growing partnership between academic, biotechnology and pharmaceutical companies

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global epigenetics market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:
  • Product Development: Product portfolios of the top players in the epigenetics market.
  • Competitive Assessment: In-depth assessment of the business segments and product portfolios of the leading players in the epigenetics market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various epigenetics products and services across geographies.
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
  1.3.1 MARKETS COVERED
  1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3 MARKET SHARE ESTIMATION
  2.3.1 KEY DATA FROM SECONDARY SOURCES
  2.3.2 KEY DATA FROM PRIMARY SOURCES
  2.3.3 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 GLOBAL EPIGENETICS MARKET OVERVIEW
4.2 LIFE CYCLE ANALYSIS, BY REGION

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
  5.2.1 EPIGENETICS MARKET SEGMENTATION: BY PRODUCT
  5.2.2 EPIGENETICS MARKET SEGMENTATION: BY RESEARCH AREA
5.3 MARKET DYNAMICS
  5.3.1 DRIVERS
    5.3.1.1 High prevalence of cancer
    5.3.1.2 Growing funding for epigenetics-based research
    5.3.1.3 Increasing intensity of research activities in the field of epigenetics
    5.3.1.4 Growing application of epigenetics in non-oncology diseases
    5.3.1.5 Growth in the number of partnerships between academic institutes and biotechnology & pharmaceutical companies for epigenetic-based products
  5.3.2 RESTRAINTS
    5.3.2.1 High cost of instruments
    5.3.2.2 Lack of trained professionals
  5.3.3 OPPORTUNITIES
    5.3.3.1 Emerging markets to present significant growth opportunities

6 EPIGENETICS MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 ENZYMES
  6.2.1 DNA-MODIFYING ENZYMES
  6.2.2 PROTEIN-MODIFYING ENZYMES
  6.2.3 RNA-MODIFYING ENZYMES
6.3 INSTRUMENTS AND CONSUMABLES
  6.3.1 MASS SPECTROMETERS
  6.3.2 NEXT-GENERATION SEQUENCERS
  6.3.3 QPCR
  6.3.4 SONICATORS
  6.3.5 OTHER EPIGENETICS INSTRUMENTS AND CONSUMABLES
6.4 KITS
  6.4.1 BISULFITE CONVERSION KITS
  6.4.2 CHIP-SEQ KITS
  6.4.3 RNA SEQUENCING KITS
  6.4.4 WHOLE-GENOME AMPLIFICATION KITS
  6.4.5 5-HMC AND 5-MC ANALYSIS KITS
  6.4.6 OTHER EPIGENETICS KITS
6.5 REAGENTS
  6.5.1 ANTIBODIES
  6.5.2 BUFFERS
  6.5.3 HISTONES
  6.5.4 MAGNETIC BEADS
  6.5.5 PRIMERS
  6.5.6 OTHER EPIGENETICS REAGENTS

7 EPIGENETICS MARKET, BY RESEARCH AREA

7.1 INTRODUCTION
7.2 DEVELOPMENTAL BIOLOGY
7.3 DRUG DISCOVERY
7.4 ONCOLOGY
7.5 OTHER RESEARCH AREAS

8 EPIGENETICS MARKET, BY REGION

8.1 INTRODUCTION
8.2 NORTH AMERICA
  8.2.1 U.S.
  8.2.2 CANADA
8.3 EUROPE
8.4 ASIA
8.5 REST OF THE WORLD (ROW)

9 COMPETITIVE LANDSCAPE

9.1 INTRODUCTION
9.2 STRATEGIC OVERVIEW
9.3 LEADING PLAYERS IN THE EPIGENETICS MARKET
9.4 COMPETITIVE SITUATION AND TRENDS
  9.4.1 NEW PRODUCT AND SERVICE LAUNCHES
  9.4.2 AGREEMENTS, ALLIANCES, COLLABORATIONS, AND PARTNERSHIPS
  9.4.3 ACQUISITIONS
  9.4.4 EXPANSIONS
  9.4.5 OTHER DEVELOPMENTS

10 COMPANY PROFILES

(Overview, Financials, Products & Services, Strategy, & Developments)*

10.1 INTRODUCTION
10.2 ABCAM PLC
10.3 ACTIVE MOTIF
10.4 DIAGENODE, INC.
10.5 ILLUMINA, INC.
10.6 MERCK & CO., INC.
10.7 NEW ENGLAND BIOLABS
10.8 QIAGEN N.V.
10.9 SIGMA-ALDRICH CORPORATION
10.10 THERMO FISHER SCIENTIFIC, INC.
10.11 ZYMO RESEARCH CORPORATION

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

11 APPENDIX

11.1 INSIGHTS OF INDUSTRY EXPERTS
11.2 DISCUSSION GUIDE
11.3 OTHER DEVELOPMENTS
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
11.5 AVAILABLE CUSTOMIZATIONS
11.6 RELATED REPORTS

LIST OF TABLES

Table 1 EPIGENETICS MARKET SNAPSHOT
Table 2 HIGH PREVALENCE OF CANCER IS A MAJOR FACTOR DRIVING MARKET GROWTH
Table 3 HIGH COST OF INSTRUMENTS TO RESTRAIN MARKET GROWTH
Table 4 EMERGING ECONOMIES EXPECTED TO OFFER GROWTH OPPORTUNITIES IN THE COMING YEARS
Table 5 EPIGENETICS MARKET SIZE, BY PRODUCT, 2012–2020 (USD MILLION)
Table 6 EPIGENETICS ENZYMES MARKET SIZE, BY TYPE, 2012–2020 (USD MILLION)
Table 7 EPIGENETICS ENZYMES MARKET SIZE, BY REGION, 2012–2020 (USD MILLION)
Table 8 EPIGENETICS MARKET SIZE FOR DNA-MODIFYING ENZYMES, BY TYPE, 2012–2020 (USD MILLION)
Table 9 EPIGENETICS MARKET SIZE FOR DNA-MODIFYING ENZYMES, BY REGION, 2012–2020 (USD MILLION)
Table 10 EPIGENETICS MARKET SIZE FOR PROTEIN-MODIFYING ENZYMES, BY TYPE, 2012–2020 (USD MILLION)
Table 11 EPIGENETICS MARKET SIZE FOR PROTEIN-MODIFYING ENZYMES, BY REGION, 2012–2020 (USD MILLION)
Table 12 EPIGENETICS MARKET SIZE FOR RNA-MODIFYING ENZYMES, BY TYPE, 2012–2020 (USD MILLION)
Table 13 EPIGENETICS MARKET SIZE FOR RNA-MODIFYING ENZYMES, BY REGION, 2012–2020 (USD MILLION)
Table 14 EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET SIZE, BY TYPE, 2012–2020 (USD MILLION)
Table 15 EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET SIZE, BY REGION, 2012–2020 (USD MILLION)
Table 16 EPIGENETICS MARKET SIZE FOR MASS SPECTROMETERS, BY REGION, 2012–2020 (USD MILLION)
Table 17 EPIGENETICS MARKET SIZE FOR NEXT-GENERATION SEQUENCERS, BY REGION, 2012–2020 (USD MILLION)
Table 18 EPIGENETICS MARKET SIZE FOR QPCR, BY REGION, 2012–2020 (USD MILLION)
Table 19 EPIGENETICS MARKET SIZE FOR SONICATORS, BY REGION, 2012–2020 (USD MILLION)
Table 20 EPIGENETICS MARKET SIZE FOR OTHER INSTRUMENTS AND CONSUMABLES, BY REGION, 2012–2020 (USD MILLION)
Table 21 EPIGENETICS KITS MARKET SIZE, BY TYPE, 2012–2020 (USD MILLION)
Table 22 EPIGENETICS KITS MARKET SIZE, BY REGION, 2012–2020 (USD MILLION)
Table 23 EPIGENETICS MARKET SIZE FOR BISULFITE CONVERSION KITS, BY REGION, 2012–2020 (USD MILLION)
Table 24 EPIGENETICS MARKET SIZE FOR CHIP-SEQ KITS, BY REGION, 2012–2020 (USD MILLION)
Table 25 EPIGENETICS MARKET SIZE FOR RNA SEQUENCING KITS, BY REGION, 2012–2020 (USD MILLION)
Table 26 EPIGENETICS MARKET SIZE FOR WHOLE-GENOME AMPLIFICATION KITS, BY REGION, 2012–2020 (USD MILLION)
Table 27 EPIGENETICS MARKET SIZE FOR 5-HMC AND 5-MC ANALYSIS KITS, BY REGION, 2012–2020 (USD MILLION)
Table 28 OTHER EPIGENETICS KITS MARKET SIZE, BY REGION, 2012–2020 (USD MILLION)
Table 29 EPIGENETICS REAGENTS MARKET SIZE, BY TYPE, 2012–2020 (USD MILLION)
Table 30 EPIGENETICS REAGENTS MARKET SIZE, BY REGION, 2012–2020 (USD MILLION)
Table 31 EPIGENETICS MARKET SIZE FOR ANTIBODIES, BY REGION, 2012–2020 (USD MILLION)
Table 32 EPIGENETICS MARKET SIZE FOR BUFFERS, BY REGION, 2012–2020 (USD MILLION)
Table 33 EPIGENETICS MARKET SIZE FOR HISTONES, BY REGION, 2012–2020 (USD MILLION)
Table 34 EPIGENETICS MARKET SIZE FOR MAGNETIC BEADS, BY REGION, 2012–2020 (USD MILLION)
Table 35 EPIGENETICS MARKET SIZE FOR PRIMERS, BY REGION, 2012–2020 (USD MILLION)
Table 36 OTHER EPIGENETICS REAGENTS MARKET SIZE, BY REGION, 2012–2020 (USD MILLION)
Table 37 EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2012–2020 (USD MILLION)
Table 38 EPIGENETICS MARKET SIZE FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2012–2020 (USD MILLION)
Table 39 EPIGENETICS MARKET SIZE FOR DRUG DISCOVERY, BY REGION, 2012–2020 (USD MILLION)
Table 40 EPIGENETICS MARKET SIZE FOR ONCOLOGY, BY REGION, 2012–2020 (USD MILLION)
Table 41 EPIGENETICS MARKET SIZE FOR OTHER RESEARCH AREAS, BY REGION, 2012–2020 (USD MILLION)
Table 42 EPIGENETICS MARKET SIZE, BY REGION, 2012–2020 (USD MILLION)
Table 43 NORTH AMERICA: EPIGENETICS MARKET SIZE, BY COUNTRY, 2012–2020 (USD MILLION)
Table 44 NORTH AMERICA: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012–2020 (USD MILLION)
Table 45 NORTH AMERICA: EPIGENETICS ENZYME MARKET SIZE, BY TYPE, 2012–2020 (USD MILLION)
Table 46 NORTH AMERICA: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE, 2012–2020 (USD MILLION)
Table 47 NORTH AMERICA: EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2012–2020 (USD MILLION)
Table 48 U.S.: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012–2020 (USD MILLION)
Table 49 U.S.: EPIGENETICS MARKET SIZE, BY ENZYME, 2012–2020 (USD MILLION)
Table 50 U.S.: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE, 2012–2020 (USD MILLION)
Table 51 U.S.: EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2012–2020 (USD MILLION)
Table 52 CANADA: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012–2020 (USD MILLION)
Table 53 CANADA: EPIGENETICS MARKET SIZE, BY ENZYME, 2012–2020 (USD MILLION)
Table 54 CANADA: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE, 2012–2020 (USD MILLION)
Table 55 CANADA: EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2012–2020 (USD MILLION)
Table 56 EUROPE: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012–2020 (USD MILLION)
Table 57 EUROPE: EPIGENETICS MARKET SIZE, BY ENZYME, 2012–2020 (USD MILLION)
Table 58 EUROPE: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE, 2012–2020 (USD MILLION)
Table 59 EUROPE: EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2012–2020 (USD MILLION)
Table 60 ASIA: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012–2020 (USD MILLION)
Table 61 ASIA: EPIGENETICS MARKET SIZE, BY ENZYME, 2012–2020 (USD MILLION)
Table 62 ASIA: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE, 2012–2020 (USD MILLION)
Table 63 ASIA: EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2012–2020 (USD MILLION)
Table 64 ROW: EPIGENETICS MARKET SIZE, BY PRODUCT, 2012–2020 (USD MILLION)
Table 65 ROW: EPIGENETICS MARKET SIZE, BY ENZYME, 2012–2020 (USD MILLION)
Table 66 ROW: EPIGENETICS MARKET SIZE, BY INSTRUMENT AND CONSUMABLE, 2012–2020 (USD MILLION)
Table 67 ROW: EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2012–2020 (USD MILLION)
Table 68 RANK OF COMPANIES IN THE GLOBAL EPIGENETICS MARKET, 2015
Table 69 MARKET DEVELOPMENTS, 2011–2015
Table 70 NEW PRODUCT AND SERVICE LAUNCHES, 2011–2015
Table 71 AGREEMENTS, ALLIANCES, COLLABORATIONS, AND PARTNERSHIPS, 2011–2015
Table 72 ACQUISITIONS, 2011–2015
Table 73 EXPANSIONS, 2011–2015
Table 74 OTHER DEVELOPMENTS, 2011–2015
Table 75 LIST OF DEVELOPMENTS FOR ABCAM PLC, 2011-2015
Table 76 LIST OF DEVELOPMENTS FOR ACTIVE MOTIF, 2011-2015
Table 77 LIST OF DEVELOPMENTS FOR DIAGENODE, INC., 2011-2015
Table 78 LIST OF DEVELOPMENTS FOR ILLUMINA, INC., 2011-2015
Table 79 LIST OF DEVELOPMENTS FOR MERCK & CO., INC., 2011-2015
Table 80 LIST OF DEVELOPMENTS FOR NEW ENGLAND BIOLABS, 2011-2015
Table 81 LIST OF DEVELOPMENTS FOR QIAGEN N.V., 2011-2015
Table 82 LIST OF DEVELOPMENTS FOR SIGMA-ALDRICH CORPORATION, 2011-2015
Table 83 LIST OF DEVELOPMENTS FOR THERMO FISHER SCIENTIFIC, INC., 2011-2015
Table 84 LIST OF DEVELOPMENTS FOR ZYMO RESEARCH CORPORATION, 2011-2015

LIST OF FIGURES

Figure 1 EPIGENETICS MARKET
Figure 2 RESEARCH DESIGN
Figure 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 6 DATA TRIANGULATION METHODOLOGY
Figure 7 EPIGENETICS MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION)
Figure 8 EPIGENETICS MARKET SIZE, BY RESEARCH AREA, 2015 VS. 2020 (USD MILLION)
Figure 9 EPIGENETICS MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION)
Figure 10 HIGH PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
Figure 11 ONCOLOGY SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015
Figure 12 ASIA TO GROW AT THE HIGHEST RATE IN THE FORECAST PERIOD (2015–2020)
Figure 13 ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES
Figure 14 EPIGENETICS MARKET: BY PRODUCT
Figure 15 EPIGENETICS MARKET: BY RESEARCH AREA
Figure 16 EPIGENETICS MARKET: DRIVERS, RESTRAINTS, & OPPORTUNITIES
Figure 17 EPIGENETICS MARKET SEGMENTATION, BY PRODUCT
Figure 18 KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN 2015
Figure 19 EPIGENETICS ENZYMES MARKET SEGMENTATION, BY TYPE
Figure 20 DNA-MODIFYING ENZYMES TO DOMINATE THE EPIGENETICS ENZYMES MARKET IN 2015
Figure 21 NORTH AMERICA TO FORM THE LARGEST REGIONAL SEGMENT OF THE EPIGENETICS ENZYMES MARKET
Figure 22 DNA-MODIFYING ENZYMES MARKET SEGMENTATION, BY TYPE
Figure 23 PROTEIN-MODIFYING ENZYMES MARKET SEGMENTATION, BY TYPE
Figure 24 RNA-MODIFYING ENZYMES MARKET SEGMENTATION, BY TYPE
Figure 25 EPIGENETICS INSTRUMENTS & CONSUMABLES MARKET, BY TYPE
Figure 26 NEXT-GENERATION SEQUENCERS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET IN 2015
Figure 27 ASIA—THE FASTEST-GROWING REGIONAL MARKET FOR EPIGENETICS INSTRUMENTS AND CONSUMABLES BETWEEN 2015 AND 2020
Figure 28 EPIGENETICS KITS MARKET SEGMENTATION, BY TYPE
Figure 29 CHIP-SEQ KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS KITS MARKET IN 2015
Figure 30 ASIA TO FORM THE FASTEST-GROWING REGIONAL MARKET FOR EPIGENETICS KITS
Figure 31 EPIGENETICS REAGENTS MARKET SEGMENTATION, BY TYPE
Figure 32 ANTIBODIES TO FORM THE LARGEST SEGMENT OF THE EPIGENETICS REAGENTS MARKET IN 2020
Figure 33 NORTH AMERICA HOLDS THE LARGEST SHARE FOR THE EPIGENETICS REAGENTS MARKET BETWEEN 2015 AND 2020
Figure 34 EPIGENETICS MARKET SEGMENTATION, BY RESEARCH AREA
Figure 35 ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN 2015
Figure 36 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY
Figure 37 NORTH AMERICA EXPECTED TO DOMINATE THE EPIGENETICS MARKET FOR DRUG DISCOVERY DURING THE FORECAST PERIOD
Figure 38 NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET FOR ONCOLOGY
Figure 39 NORTH AMERICA TO FORM THE LARGEST REGIONAL SEGMENT OF THE OTHER EPIGENETICS RESEARCH AREAS MARKET
Figure 40 GLOBAL: ECONOMIC INDICATORS
Figure 41 EPIGENETICS MARKET SEGMENTATION, BY REGION
Figure 42 ASIA TO BE THE FASTEST-GROWING REGION DURING THE FORECAST PERIOD
Figure 43 EPIGENETICS MARKET IN ASIA TO WITNESS THE HIGHEST GROWTH FROM 2015 TO 2020
Figure 44 NORTH AMERICA: ECONOMIC INDICATORS
Figure 45 NORTH AMERICA: MARKET SNAPSHOT
Figure 46 U.S. FORMS THE FASTEST-GROWING MARKET IN NORTH AMERICA IN 2015
Figure 47 KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN NORTH AMERICA IN 2015
Figure 48 DNA-MODIFYING ENZYMES SEGMENT DOMINATES THE ENZYME MARKET IN NORTH AMERICA IN 2015
Figure 49 NEXT-GENERATION SEQUENCERS SEGMENT HOLDS LARGEST SHARE IN THE NORTH AMERICAN INSTRUMENTS AND CONSUMABLES MARKET IN 2015
Figure 50 ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN NORTH AMERICA IN 2015
Figure 51 KITS COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN THE U.S. IN 2015
Figure 52 DNA-MODIFYING ENZYMES TO COMMAND THE LARGEST SHARE IN THE EPIGENETICS ENZYME MARKET IN THE U.S. IN 2015
Figure 53 NEXT-GENERATION SEQUENCERS TO ACCOUNT FOR THE LARGEST SHARE IN THE EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET IN THE U.S. IN 2015
Figure 54 ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN THE U.S. IN 2015
Figure 55 KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN CANADA IN 2015
Figure 56 DNA-MODIFYING ENZYMES TO COMMAND THE LARGEST SHARE IN THE EPIGENETICS ENZYME MARKET IN CANADA IN 2015
Figure 57 NEXT-GENERATION SEQUENCERS TO ACCOUNT FOR THE LARGEST SHARE IN THE CANADIAN INSTRUMENTS AND CONSUMABLES MARKET IN 2015
Figure 58 ONCOLOGY FORMS THE LARGEST RESEARCH AREAS SEGMENT IN CANADA IN 2015
Figure 59 EUROPE: ECONOMIC INDICATORS
Figure 60 KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN EUROPE IN 2015
Figure 61 DNA-MODIFYING ENZYMES SEGMENT TO COMMAND THE LARGEST SHARE IN THE EUROPEAN ENZYME MARKET IN 2015
Figure 62 NEXT-GENERATION SEQUENCERS SEGMENT HOLDS THE LARGEST SHARE IN THE EUROPEAN INSTRUMENTS AND CONSUMABLES MARKET (2015)
Figure 63 ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN EUROPE IN 2015
Figure 64 ASIA: ECONOMIC INDICATORS
Figure 65 ASIA: MARKET SNAPSHOT
Figure 66 KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN ASIA IN 2015
Figure 67 DNA-MODIFYING ENZYMES SEGMENT DOMINATES THE ASIAN MARKET IN 2015
Figure 68 NEXT-GENERATION SEQUENCERS TO HOLD THE LARGEST MARKET SHARE IN THE ASIAN INSTRUMENTS AND CONSUMABLES MARKET, IN 2015
Figure 69 ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN ASIA IN 2015
Figure 70 REST OF THE WORLD: ECONOMIC INDICATORS
Figure 71 KITS TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN ROW IN 2015
Figure 72 DNA-MODIFYING ENZYMES WILL DOMINATE ROW MARKET IN 2015
Figure 73 NEXT-GENERATION SEQUENCERS TO FORM THE LARGEST INSTRUMENT AND CONSUMABLE SEGMENT OF THE ROW MARKET
Figure 74 ONCOLOGY TO FORM THE LARGEST RESEARCH AREA SEGMENT IN ROW IN 2015
Figure 75 NEW PRODUCT LAUNCHES IS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE EPIGENETICS MARKET
Figure 76 FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS
Figure 77 ABCAM PLC: COMPANY SNAPSHOT
Figure 78 ILLUMINA, INC.: COMPANY SNAPSHOT
Figure 79 MERCK & CO., INC.: COMPANY SNAPSHOT
Figure 80 QIAGEN N.V.: COMPANY SNAPSHOT
Figure 81 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT
Figure 82 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
Skip to top


Ask Your Question

Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: